Send me a link:

*Text messaging rates may apply.

 Dow Down 0.16% Nasdaq Up 0.40%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
173.08 5.11(3.04%) Jul 23, 4:00PM EDT
Prev Close:167.97
Open:168.65
Bid:120.00 x 200
Ask:183.36 x 100
1y Target Est:193.89
Beta:0.51
Next Earnings Date:24-Jul-14ALXN Earnings announcement
Day's Range:168.23 - 173.49
52wk Range:100.89 - 185.43
Volume:1,753,224
Avg Vol (3m):1,253,840
Market Cap:34.23B
P/E (ttm):104.64
EPS (ttm):1.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALXNUp 3.04%34.23B
AMGN92.36B
BAX41.69B

Key Statistics

Forward P/E (1 yr):30.96
P/S (ttm):18.68
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :4.86
Quarterly EPS Est (Jun-14) :1.07
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.14

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback